U.S.-Canada Tensions Expose North American Health Security Vulnerabilities in Pharmaceutical Supply Chains
Recent tensions between the U.S. and Canada, including the imposition of tariffs and countermeasures, are raising concerns about the resilience of critical supply chains, particularly in the pharmaceutical sector. Despite a deeply integrated trade relationship, economic interdependence between the two allies is revealing vulnerabilities during periods of geopolitical strain. Canada, for instance, is highly reliant on foreign pharmaceutical supply chains, with imports accounting for a significant portion of its domestic drug expenditures. The issue is not merely foreign dependence but a reliance on a limited number of suppliers for critical medicines and active pharmaceutical ingredients (APIs). Disruptions in production, transportation, or trade from a single source can leave Canada with few alternatives, impacting health security. NATO acknowledges that such strategic dependencies can limit crisis response and that disruptions in one area can have cascading effects.
